![Supplemental Materials for Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet Supplemental Materials for Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000997343/2003701320/gr1.gif)
Supplemental Materials for Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet
![Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e00989d3-526c-47d7-8e66-016f9782af61/gr3_lrg.jpg)
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet
![unges zum Mitnehmen Gratis Prominenten-Porträt Dr. Gerhard Koch, Vorsitzender des Fördervereins für ein stationäres Hospiz in Hagen - PDF Free Download unges zum Mitnehmen Gratis Prominenten-Porträt Dr. Gerhard Koch, Vorsitzender des Fördervereins für ein stationäres Hospiz in Hagen - PDF Free Download](https://docplayer.org/docs-images/97/133820274/images/6-1.jpg)